Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …

JR Chong, NJ Ashton, TK Karikari… - Alzheimer's & …, 2021 - Wiley Online Library
Introduction There is increasing evidence that phosphorylated tau (P‐tau181) is a specific
biomarker for Alzheimer's disease (AD) pathology, but its potential utility in non‐White …
被引用次数：44 相关文章

Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …

JR Chong, NJ Ashton, TK Karikari… - Alzheimer's & …, 2021 - discovery.ucl.ac.uk
INTRODUCTION: There is increasing evidence that phosphorylated tau (P-tau181) is a
specific biomarker for Alzheimer's disease (AD) pathology, but its potential utility in non …

Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …

JR Chong, NJ Ashton, TK Karikari… - … & Dementia: the …, 2021 - europepmc.org
Methods Single molecule array (Simoa) measurements of plasma P-tau181, total tau,
amyloid beta (Aβ) 40 and Aβ42, as well as derived ratios were correlated with neuroimaging …

Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …

JR Chong, NJ Ashton, TK Karikari… - … & Dementia: The …, 2021 - psycnet.apa.org
Introduction: There is increasing evidence that phosphorylated tau (P‐tau181) is a specific
biomarker for Alzheimer's disease (AD) pathology, but its potential utility in non‐White …

Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …

JR Chong, NJ Ashton, TK Karikari… - Alzheimer's and …, 2021 - research.sahmri.org.au
Introduction: There is increasing evidence that phosphorylated tau (P-tau181) is a specific
biomarker for Alzheimer's disease (AD) pathology, but its potential utility in non-White patient …

Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …

JR Chong, NJ Ashton, TK Karikari, T Tanaka… - 2021 - scholarbank.nus.edu.sg
Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal
atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular …

Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …

JR Chong, NJ Ashton, TK Karikari… - Alzheimer's and …, 2021 - profiles.wustl.edu
Introduction: There is increasing evidence that phosphorylated tau (P-tau181) is a specific
biomarker for Alzheimer's disease (AD) pathology, but its potential utility in non-White patient …

Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …

JR Chong, NJ Ashton, TK Karikari… - … & dementia: the …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction There is increasing evidence that phosphorylated tau (P-tau181) is a specific
biomarker for Alzheimer's disease (AD) pathology, but its potential utility in non-White patient …